Internal Coverage Criteria
The Oncology Institute follows evidence-based medical policies to guide coverage decisions and ensure that patients receive appropriate, high-quality care. The following policies are publicly available for your reference:
Medical Policies
- Intravenous Iron Replacement Policy
- Pluvicto® for Treatment of Metastatic Castrate-Resistant Prostate Cancer Policy
These policies describe clinical indications, eligibility requirements, and other key considerations used in determining coverage. They are reviewed and updated regularly to reflect the latest clinical evidence and regulatory standards.
